Allakos Inc (ALLK) Stock Price Today
French firms boost AI-driven cybersecurity, focusing on productivity and operational results over processes.
A new study by Securonix shows French organizations are increasingly adopting AI-driven cybersecurity operations, prioritizing productivity and measurable outcomes rather than just processes. French firms lead in allowing AI to automatically trigger ...

Exosens secures a major order for 25,000 light intensifier tubes for night vision devices through 2030.
Exosens has received a firm order for 25,000 high-performance 4G+ light intensifier tubes to equip night vision products for Theon, under a long-term supply agreement extended through 2030. The order includes options for an additional 35,000 tubes, p...

Exosens wins order for 25,000 image intensifier tubes to boost European night vision tech.
Exosens secured a firm order to supply 25,000 high-performance 4G+ image intensifier tubes to Theon Sensors for integration into night vision devices, with deliveries starting late 2026. This order is part of a long-term agreement through 2030 and in...

FDA updates MYQORZO label with Phase 3 data showing it outperforms beta-blocker metoprolol in treating oHCM.
Cytokinetics announced FDA approval to update MYQORZO's prescribing information to include Phase 3 MAPLE-HCM trial data comparing MYQORZO (aficamten) to the beta-blocker metoprolol in adults with symptomatic obstructive hypertrophic cardiomyopathy (o...

VirTra names Caleb Rauch as new Director of Operations to boost manufacturing and growth.
VirTra, a global provider of use-of-force and firearms training simulators, appointed Caleb Rauch as Director of Operations effective November 16, 2026. Rauch brings over 15 years of manufacturing and operations experience, notably in aerospace compo...

Beer tops Brits' drink choices, with no and low-alcohol options growing in popularity.
New research by Budweiser Brewing Group shows beer is the most popular alcoholic drink among Brits, preferred by 30% over wine and spirits. No and low-alcohol beer options are also leading the moderation trend, chosen by 18.5% of respondents, nearly ...

Aclaris starts Phase 2b trial of modzatinib for lichen planus, aiming for first oral therapy with FDA Fast Track status.
Aclaris Therapeutics has initiated a Phase 2b clinical trial for modzatinib (ATI-2138), targeting moderate-to-severe lichen planus (LP), a chronic inflammatory disease with no approved treatments. Modzatinib uniquely inhibits ITK and JAK3 pathways, p...

Iovance's revenue jumps 77% but lung cancer trial results drag stock down 48%
Iovance Biotherapeutics reported a strong quarter with Amtagvi revenue up 77% to $101.6 million and nearly halted cash burn at -$4.47 million. However, disappointing lung cancer trial results caused the stock to drop 47.6% since October 28, as the re...

Riverside and Questcorp start Phase 2B drilling at La Union gold project in Sonora, Mexico
Riverside Resources and Questcorp Mining have begun Phase 2B of their reverse circulation drilling program at the La Union Project in Sonora, Mexico. The program targets gold mineralization at Luis Hill and the Union Mine, testing new geophysical ano...

Harrow Inc. nears $350M 2026 revenue goal after strong Q3 growth and expanded sales efforts.
Harrow Inc., a Nashville-based ophthalmology company, showed strong Q3 performance with significant quarter-over-quarter growth in its products VEVYE (up 35%) and IHEEZO (up 62%). The company is expanding its commercial coverage and sales team, which...

All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.